Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending January 09, 2006. The report serves to disclose details regarding the appointment of two new Non-Executive Directors to the Board, effective January 1, 2006, in compliance with the Financial Services Authority's Listing Rules.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a corporate governance disclosure and does not contain financial performance data.
Material Changes
The material change reported is the appointment of the following individuals as Non-Executive Directors:
- Dr. Ralph Horwitz: Appointed effective January 1, 2006. He has not been a director of a publicly quoted company in the past five years and holds no notifiable interests in GSK shares.
- Mr. Tom de Swaan: Appointed effective January 1, 2006. He holds no notifiable interests in GSK shares. His recent directorships include ABN AMRO Bank N.V., ABN AMRO Holding N.V., and Saudi Hollandi Bank. He previously served as a director for LeasePlan Corporation N.V.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. The document is limited to director biographical details and compliance confirmations.
Investor Verification Checklist
- Confirm the effective date of the new director appointments (January 1, 2006).
- Verify the absence of notifiable share interests for both Dr. Horwitz and Mr. de Swaan.
- Review the past five-year directorship history of Mr. de Swaan for potential conflicts of interest.
- Note that this filing contains no financial results; refer to Form 20-F for financial data.